0001209191-15-078124.txt : 20151103
0001209191-15-078124.hdr.sgml : 20151103
20151103165801
ACCESSION NUMBER: 0001209191-15-078124
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151026
FILED AS OF DATE: 20151103
DATE AS OF CHANGE: 20151103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIND Therapeutics, Inc
CENTRAL INDEX KEY: 0001385228
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174913400
MAIL ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences, Inc
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences Inc
DATE OF NAME CHANGE: 20070105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TROIANO GREGORY
CENTRAL INDEX KEY: 0001656781
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36072
FILM NUMBER: 151194390
MAIL ADDRESS:
STREET 1: C/O BIND THERAPEUTICS, INC.
STREET 2: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-10-26
0
0001385228
BIND Therapeutics, Inc
BIND
0001656781
TROIANO GREGORY
C/O BIND THERAPEUTICS, INC.
325 VASSAR STREET
CAMBRIDGE
MA
02139
0
1
0
0
SENIOR VICE PRESIDENT
Common Stock
5343
D
Employee Stock Option (Right to Buy)
1.21
2019-05-04
Common Stock
2226
D
Employee Stock Option (Right to Buy)
1.21
2020-02-18
Common Stock
1526
D
Employee Stock Option (Right to Buy)
1.63
2021-04-25
Common Stock
6488
D
Employee Stock Option (Right to Buy)
2.52
2022-04-23
Common Stock
3005
D
Employee Stock Option (Right to Buy)
2.78
2023-04-22
Common Stock
2522
D
Employee Stock Option (Right to Buy)
13.58
2024-03-02
Common Stock
8710
D
Employee Stock Option (Right to Buy)
5.96
2025-03-05
Common Stock
13000
D
Beginning on May 5, 2009, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
The number of shares underlying the stock option granted to the Reporting Person was 3,816. The Reporting Person has exercised his option to purchase 1,590 of such shares.
Beginning on February 19, 2010, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Beginning on April 26, 2011, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Beginning on April 24, 2012, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Beginning on April 26, 2013, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Beginning on March 3, 2014, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Beginning on March 6, 2015, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Exhibit List: Exhibit 24.1 - Power of Attorney
/s/ Andrew Hirsch, Attorney-in-Fact for Gregory Troiano
2015-11-03
EX-24.3_612630
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Gregory Troiano
With respect to holdings of and transactions in securities issued by BIND
Therapeutics, Inc. (the "Company"), the undersigned hereby constitutes and
appoints the individuals named on Schedule A attached hereto, as may be amended
from time to time, or any of them signing singly, with full power of
substitution and resubstitution, to act as the undersigned's true and lawful
attorney-in-fact to:
1. prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the United States Securities and Exchange Commission (the "SEC") a
Form ID, including amendments thereto, and any other documents necessary or
appropriate to obtain and/or regenerate codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required by
Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or
regulation of the SEC;
2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance
with Section 16 of the Securities Exchange Act of 1934, as amended, and the
rules thereunder;
3. do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar authority; and
4. take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in his or
her discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution and
resubstitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is any Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 26 day of October, 2015.
/s/ Gregory Troiano
Gregory Troiano
Schedule A
Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and
Resubstitution
1. Andrew Hirsch
2. Christopher M. Lindblom